載入...
Latrepirdine, a potential novel treatment for Alzheimer’s disease and Huntington’s chorea
Latrepirdine (Dimebon) is a novel compound currently under development by Medivation Inc and Pfizer Inc for the treatment of Alzheimer’s disease and Huntington’s chorea. Originally developed and marketed as an antihistamine in Russia, it has potential for the treatment of neurodegenerative diseases....
Na minha lista:
| Main Authors: | , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2010
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3346261/ https://ncbi.nlm.nih.gov/pubmed/20047162 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|